Markets face a defining 48 hours. Over 1,800 companies report this week. The positioning data tells a stark story: shorts are leaning in hard ahead of the biggest prints.
PLTR kicks things off today after the close. AMD and CAT follow Tuesday. Wednesday brings LLY, the $1 trillion pharma leader whose GLP-1 results will set the tone for the whole sector. BKNG also reports Tuesday — and notably, short sellers have been retreating there. Bears appear to be picking their battles rather than fighting every name.
The most aggressive positioning sits in names with the most to lose. HTZ short interest hit 84.6% of free float. Availability is zero — no shares left to borrow. jumped from 72% to 82% SI in one week as bears rebuilt ahead of its print. is a squeeze setup: 43% SI, cost to borrow at 15.1% APR, and zero availability. has borrow locked out entirely with options market on edge.
JCI, BMY, and ZBRA all saw downgrades on August 2. Bristol-Myers Squibb's consensus target edged down to $64.91. Meanwhile, analysts are piling into HONA — Honeywell Aerospace — ahead of its first full earnings season as a standalone company.
The FT flagged a notable development in currency markets. The New York Fed intervened in the yen market, selling euros to buy yen. The Japanese yen jumped 3% on intervention speculation. South Korean stocks soared 18% as AI-related buying returned. SNDK heads into its print with a collapsed short base and analysts sitting nearly $1,000 above the current price.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
